ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 83 filers reported holding ONCOMED PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $144,000 | -22.6% | 61,985 | +6.2% | 0.00% | – |
| Q1 2018 | $186,000 | -17.7% | 58,373 | +5.9% | 0.00% | – |
| Q4 2017 | $226,000 | -1.7% | 55,097 | +8.6% | 0.00% | – |
| Q3 2017 | $230,000 | +49.4% | 50,729 | +10.3% | 0.00% | – |
| Q2 2017 | $154,000 | -79.6% | 46,012 | -43.9% | 0.00% | -100.0% |
| Q1 2017 | $756,000 | +26.6% | 81,999 | +6.0% | 0.00% | 0.0% |
| Q4 2016 | $597,000 | -28.7% | 77,382 | +5.7% | 0.00% | 0.0% |
| Q3 2016 | $837,000 | +58.5% | 73,224 | +71.0% | 0.00% | 0.0% |
| Q2 2016 | $528,000 | +23.7% | 42,821 | +1.4% | 0.00% | 0.0% |
| Q1 2016 | $427,000 | -54.4% | 42,233 | +1.7% | 0.00% | 0.0% |
| Q4 2015 | $936,000 | +38.9% | 41,519 | +2.2% | 0.00% | 0.0% |
| Q3 2015 | $674,000 | -21.5% | 40,609 | +6.5% | 0.00% | 0.0% |
| Q2 2015 | $859,000 | +7.1% | 38,144 | +22.7% | 0.00% | 0.0% |
| Q1 2015 | $802,000 | +24.5% | 31,078 | +5.1% | 0.00% | 0.0% |
| Q4 2014 | $644,000 | +18.2% | 29,570 | +2.8% | 0.00% | 0.0% |
| Q3 2014 | $545,000 | +2.6% | 28,777 | +26.4% | 0.00% | 0.0% |
| Q2 2014 | $531,000 | +25.5% | 22,765 | +81.5% | 0.00% | 0.0% |
| Q1 2014 | $423,000 | +16.9% | 12,545 | +2.4% | 0.00% | 0.0% |
| Q4 2013 | $362,000 | +92.6% | 12,245 | +3.0% | 0.00% | – |
| Q3 2013 | $188,000 | – | 11,885 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|